TentaMedix extends its GMP portfolio
TentaMedix GmbH is pleased to announce the extension of its GMP relevant testing portfolio. Already in the year 2019, Te…
TentaMedix GmbH is pleased to announce the extension of its GMP relevant testing portfolio. Already in the year 2019, Te…
On the 18th of December 2019 the Tentamus company TentaMedix GmbH received the official recognition document and listing…
Already at the end of the 19th century it became known that injections can cause severe fever in patients. Substances ca…
As pyrogen testing in rabbits (Ph. Eur. 2.6.8) is from now on only allowed in exceptional cases by the European legislat…